regulation, developmental biology
Q&A: From FDA to Industry
Q&A: From FDA to Industry
Kerry Grens | Sep 27, 2016
Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.
Further Support for Early-Life Allergen Exposure
Further Support for Early-Life Allergen Exposure
Jef Akst | Sep 20, 2016
Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.
Study: Zika-Exposed Babies 50 Times More Likely to Be Born with Microcephaly
Study: Zika-Exposed Babies 50 Times More Likely to Be Born with Microcephaly
Jef Akst | Sep 16, 2016
Scientists estimate the risk to fetuses exposed to the virus in utero.
Theranos Withdraws Zika Blood Test
Theranos Withdraws Zika Blood Test
Jef Akst | Sep 1, 2016
The embattled company failed to include proper safeguards, according to federal regulators.
How a Sleep-Associated Hormone Affects Murine Tooth Development
How a Sleep-Associated Hormone Affects Murine Tooth Development
Mallory Locklear | Aug 22, 2016
Disrupting the light/dark cycles of pregnant mice, researchers observe detrimental effects in the mouths of the animals’ pups.
Theranos CEO Presents New Device
Theranos CEO Presents New Device
Kerry Grens | Aug 2, 2016
The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.
Wanted: Transcriptional Regulators
Wanted: Transcriptional Regulators
Ruth Williams | Aug 1, 2016
Researchers have designed a screen to find unique molecules, called riboswitches, that determine whether transcription will proceed.
Riboswitch Screen
Riboswitch Screen
Ruth Williams | Jul 31, 2016
A newly developed method detects regulators of bacterial transcription called riboswitches.
Theranos CEO Banned from Running Labs for Two Years
Theranos CEO Banned from Running Labs for Two Years
Tanya Lewis | Jul 8, 2016
Federal regulators also revoked a certificate for the company’s Newark, California lab.
FDA Reduces Paperwork for “Compassionate Use”
FDA Reduces Paperwork for “Compassionate Use”
Jef Akst | Jun 8, 2016
The change should allow patients with fatal illnesses easier access to experimental drugs, but gaining permission from drug companies remains the biggest challenge.